A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.
about
The cost-effectiveness of biopharmaceuticals: a look at the evidence.Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.The economics of treating chronic hepatitis B in Asia.Health state utilities and quality of life in patients with hepatitis B.HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B.Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy.Incorporated antivirals for chronic hepatitis B in Brazil: a cost-effectiveness analysis.
P2860
Q34257719-8E612310-2980-4D59-B0AB-6AA37494B5A0Q34677180-8D90F0A5-4D5F-4EF9-8A31-977A23233B90Q34996644-2CF7E0F4-115F-4A02-ADBB-C461E20050A7Q36091385-19A67D75-2F9B-4981-8EB6-9A394ED52F12Q37356782-9E14F2C1-37D5-4753-ABA3-6CB2EA65B7F8Q41673544-9F51585D-D218-4B5E-AC8D-9F92F5FF3FEAQ42248537-A847DDF4-2AFA-4A1F-A0D3-3E419BFF4D84
P2860
A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A systematic review and econom ...... atment of chronic hepatitis B.
@ast
A systematic review and econom ...... atment of chronic hepatitis B.
@en
type
label
A systematic review and econom ...... atment of chronic hepatitis B.
@ast
A systematic review and econom ...... atment of chronic hepatitis B.
@en
prefLabel
A systematic review and econom ...... atment of chronic hepatitis B.
@ast
A systematic review and econom ...... atment of chronic hepatitis B.
@en
P2093
P2860
P1476
A systematic review and econom ...... eatment of chronic hepatitis B
@en
P2093
P2860
P356
10.1111/J.1365-2893.2006.00808.X
P50
P577
2007-02-01T00:00:00Z